Synergy Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,765	Closed	-$969K	–	212
2025 Q1	$969K	Buy	8,765 +1,543	+21%	+$171K	0.12%	90
2024 Q4	$996K	Buy	+7,222	New	+$996K	0.08%	119